Exosome-based immunotherapy has been integrated into conventional treatments in a way which maximizes specific T cell activation and minimizes prevalent immunosuppressive influences of the tumor. Based on abundant experience and professional technical team, Creative Biolabs is committed to providing exosomes related services for global customers. Now, we are happy to introduce ascetic cell-derived exosomes (AEX)-based vaccines development to global clients.